ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Biopsy"

  • 2019 American Transplant Congress

    Proteomics Reveals Compartment-Specific Alterations in the Extracellular Matrix of Kidney Allografts with Antibody-Mediated Rejection

    S. Clotet Freixas1, C. McEvoy1, I. Batruch2, M. Kotlyar3, C. Pastrello3, J. Van1, A. Bozovic1, V. Kulasingam1, P. Chen4, I. Jurisica3, A. Chruscinski1, R. John1, A. Konvalinka1

    1University Health Network, Toronto, ON, Canada, 2Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada, 3Krembil Research Institute, Toronto, ON, Canada, 4Institute of Medical Science, University of Toronto, Toronto, ON, Canada

    *Purpose: Antibody-mediated rejection (AMR) is the most important cause of premature kidney graft loss. AMR is caused by anti-HLA and non-HLA antibodies against proteins in…
  • 2019 American Transplant Congress

    Post-Reperfusion Hepatic Beta-Catenin Activation Regulates Graft Damage, Inflammatory Responses and Transplant Outcomes

    H. Hirao, K. Kadono, S. Kageyama, K. Nakamura, T. Ito, J. Aziz, K. J. Dery, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

    Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA

    *Purpose: Hepatic ischemia-reperfusion injury (IRI), an innate-immune driven hepatic inflammation response, represents a major risk factor of early allograft dysfunction (EAD) and rejection in liver…
  • 2019 American Transplant Congress

    First UK Experience of the Molecular Microscope (MMDX™) in the Kidney Transplant Clinic

    C. Lawrence1, S. Thiru2, A. Manoj1, S. Fluck1

    1Renal Medicine, The Lister Hospital, Stevenage, United Kingdom, 2Histopathology, Addenbrookes Hospital, Cambridge, United Kingdom

    *Purpose: Molecular diagnostic methods are now included in the Banff classification of kidney transplant pathology. Traditional histopathology may be limited by intra/inter pathologist variation. The…
  • 2019 American Transplant Congress

    Subclinical Rejection is Common on Surveillance Biopsies in Children with Kidney Transplant

    S. Gattis1, R. Liverman1, A. Serluco1, J. Yin1, J. Hogan2, S. Jernigan2, R. George2, P. D. Winterberg2, R. Garro2

    1Children's Healthcare of Atlanta, Atlanta, GA, 2Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

    *Purpose: Surveillance biopsies provide the opportunity to identify subclinical rejection and other pathologic changes, yet their utilization varies across pediatric kidney transplant centers. The purpose…
  • 2019 American Transplant Congress

    High Prevalence of De Novo Donor-Specific Antibodies during Rejection after Liver Transplantation

    J. Colmenero, N. Flores, A. Diaz, M. Vasquez, P. Ruiz, G. Crespo, J. Martorell, M. Navasa

    Liver Transplant Unit, Hospital Clinic Barcelona, Barcelona, Spain

    *Purpose: Anti-HLA donor specific antibodies (dnDSA) after liver transplantation (LT) are currently under investigation. Recent studies show an incidence of dnDSA after LT ranging from…
  • 2018 American Transplant Congress

    Serelaxin-Notch1 Signaling Promotes Macrophage M2 Differentiation and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation: From Mouse-to-Human

    S. Kageyama,1 K. Nakamura,1 B. Ke,1 R. Sosa,2 E. Reed,2 F. Kaldas,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1Surgery, Liver Transplant, UCLA, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Background/Aim: We have documented crucial role of macrophage Notch1 signaling in a mouse warm hepatic ischemia-reperfusion injury (IRI) model. However, its clinical relevance or therapeutic…
  • 2018 American Transplant Congress

    NK Cells in Allograft Kidney Biopsies during Rejection: Detection, Quantification, and Precise Localization Using Multiplex Immunofluorescence

    M. Terada,1 J. Duong Van Huyen,2 F. Drieux,4 C. Legendre,3 P. Bruneval,1 M. Rabant.2

    1Pathology Department, Georges Pompidou European Hospital, Paris, France; 2Pathology Department, Necker-Enfants Malades Hospital, Paris, France; 3Kidney Transplantation Department, Necker-Enfants Malades Hospital, Paris, France; 4Pathology Department, Centre Henri Becquerel, Rouen, France.

    Introduction: Among the complex cellular interplay engaged in renal rejection, recent transcriptomic analysis of renal biopsies has detected NK cell transcripts in the setting of…
  • 2018 American Transplant Congress

    Distribution of Biopsy Proven Acute Rejection in a Large Pediatric Kidney Transplant Program: A Four Year Experience

    C. Varnell, Jr.,1 A. Carle,2,3 D. Hooper.1,2,3

    1Division of Nephrology & Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 3Department of Pediatrics, University of Cincinnati, Cincinnati, OH.

    Introduction: Kidney biopsy is the gold standard for diagnosing rejection, transplant glomerulopathy, and other pathology after transplantation. We aimed to understand the distribution of Banff…
  • 2018 American Transplant Congress

    “Majority Rules”: A Method to Reduce Variability in Diagnosing Antibody Mediated Rejection in Renal Allograft Biopsies Using Banff 2013

    B. Smith,1 L. Cornell,1 M. Smith,2 C. Cortese,3 X. Geiger,3 C. Schinstock,1 W. Kremers,1 M. Stegall.1

    1Mayo Clinic, Rochester, MN; 2Mayo Clinic, Scottsdale, AZ; 3Mayo Clinic, Jacksonville, FL.

    Introduction: The Banff 2013 criteria for diagnosing antibody-mediated rejection (ABMR) includes three lesions: glomerulitis (g), peritubularitis (PTC), and chronic glomerulopathy (cg). The poor reproducibility of…
  • 2018 American Transplant Congress

    Biopsy Correlates of DSA in Antibody-Mediated Rejection: C4d vs Microvascular Inflammation Scores

    C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.

    Icahn School of Medicine at Mount Sinai, New York, NY.

    Background: The diagnosis of antibody-mediated rejection (AMR) requires the presence of both the histologic features of AMR as well as donor-specific antibodies (DSA). Whether anti-HLA…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 43
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences